HIM
BIIB icon

Hermes Investment Management’s Biogen BIIB Stock Holding History

Hermes Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-134,488
Closed -$54.3M – 225
2015
Q2 		$54.3M Buy
134,488
+1,100
+0.8% +$441K 1.22% 16
2015
Q1 		$56.3M Buy
133,388
+10,050
+8% +$3.96M 1.31% 13
2014
Q4 		$41.9M Sell
123,338
-300
-0.2% -$97.1K 1.08% 23
2014
Q3 		$40.9M Buy
123,638
+32,188
+35% +$10.6M 1.05% 21
2014
Q2 		$28.8M Buy
91,450
+81,202
+792% +$24.4M 0.8% 51
2014
Q1 		$3.13M Buy
10,248
+541
+6% +$172K 0.1% 107
2013
Q4 		$2.72M Sell
9,707
-2,081
-18% -$538K 0.08% 107
2013
Q3 		$2.84M Buy
11,788
+1,591
+16% +$356K 0.1% 100
2013
Q2 		$2.19M Buy
+10,197
New +$2.18M 0.09% 120

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Hermes Investment Management's BIIB Position: Q3 2015 in Review

Hermes Investment Management sold out of Biogen (BIIB) in Q3 2015, closing a stake of 134,488 shares — an estimated $54.3M sold.

Hermes Investment Management first reported a position in BIIB in Q2 2013 and held it in 9 quarters. The position peaked at $56.3M in Q1 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Hermes Investment Management reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Hermes Investment Management sold 134,488 Biogen shares in Q3 2015, an estimated $54.3M.
  • Hermes Investment Management first reported a position in Biogen in Q2 2013 and held it in 9 quarters.
  • Hermes Investment Management's Biogen position peaked at $56.3M in Q1 2015.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Hermes Investment Management's 13F filing for Q3 2015, filed 21 Oct 2015.